权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Regulation of Erythroid Cell Progenitors by the Nuclear Receptor Transcription Factor VDR

核受体转录因子 VDR 对红细胞祖细胞的调节

基本信息

批准号：
10392918
负责人：
Margaret H Baron
金额：
$ 58.73万
依托单位：
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-04-06 至 2025-04-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10392918
关键词：
ARNTL gene ATAC-seq Ablation Adult Agonist Anemia Animals Bone Marrow Calcitriol Cell Culture Techniques Cell Line Cell Nucleus Cells Cholecalciferol Chromatin Circadian Rhythms Clinical Complex Control Animal DNA Binding Development Dexamethasone Disease Effectiveness Embryo Engineering Erythrocyte Transfusion Erythrocytes Erythroid Erythroid Progenitor Cells Erythropoiesis Fetal Liver GATA1 gene Gene Expression Gene Expression Profiling Genes Genetic Genetic Transcription Glucocorticoid Receptor Glucocorticoids Growth Hematological Disease Hematopoietic Knockout Mice Knowledge Lead Leukemic Cell Ligands Mission Modeling Molecular Conformation Molecular Target Mutation Nuclear Hormone Receptors Nuclear Receptors Output Pathway interactions Periodicity Process Production Proteins Public Health Publishing RNA Receptor Activation Receptor Signaling Recovery Regulation Reticulocytosis Role Signal Pathway Stress Testing Time United States National Institutes of Health Up-Regulation Vitamin D3 Receptor bone circadian pacemaker conditional mutant erythroid differentiation fetal knock-down mouse model mutant novel novel therapeutics progenitor receptor expression recruit response tool transcription factor virtual

项目摘要

ABSTRACT: The pathways that regulate the formation and differentiation of erythroid progenitors to red blood cells are incompletely understood. We found that the vitamin D receptor (Vdr) nuclear hormone transcription factor gene is expressed in fetal and adult stages but not at the embryonic stage of development and is downregulated during maturation. VDR activation by its ligand vitamin D3 results in conformational changes that stabilize the protein and induce its translocation into the nucleus, where it recruits coregulatory complexes. The VDR signaling pathway has been studied mostly in bone but has been largely unexplored in erythropoiesis: published studies were performed almost entirely in leukemic cell lines (not normal primary cells). Activation of Vdr signaling by the vitamin D3 agonist calcitriol increased the outgrowth of EryD colonies from fetal liver and adult bone marrow, maintained progenitor potential, and delayed erythroid maturation. The stimulation in growth of erythroid progenitors resulted in a large increase in the numbers of mature red blood cells. The early (CD71lo/neg) but not the late (CD71hi) EryD progenitor subset of Linneg cKit+ cells was responsive to calcitriol, independently of its calcemic effects. Activation of VDR could partially substitute for and synergize with the stress glucocorticoid dexamethasone in enhancing progenitor proliferation compared to either ligand alone, suggesting a role in stress erythropoiesis. This possibility is supported by our finding that an erythroid specific deletion in Vdr that interferes with DNA binding results in a reticulocytosis that occurs earlier and is more pronounced than in control animals in response to stress. RNA inhibition of Vdr expression abrogated the stimulation of early erythroid progenitor growth by calcitriol. These findings suggest that Vdr has a cell-intrinsic function in early erythroid progenitors. Activation of Vdr by calcitriol blocked the upregulation of erythroid transcription factor genes Gata1, Fog1 and Klf1. Intriguingly, circadian rhythm genes are upregulated by activation of Vdr and the glucocorticoid receptor Gr and oscillations in expression of the clock gene Per1 are promoted in erythroid progenitors. The clock gene Bmal1 is required for the proliferative response to dexamethasone. Therefore, the overarching hypothesis of this proposal is that Vdr and Gr regulate erythroid progenitors in part by modulating clock gene expression and have partially redundant functions. This application will use animal and cell culture models to explore the modulation of circadian clock gene expression by Gr and Vdr in erythroid progenitors and functional relationships between these two nuclear hormone receptor TFs. These studies may lead to the identification of novel molecular targets in erythroid progenitors that can be exploited to develop new therapies for anemias and other red cell disorders. The ability to modulate ex vivo expansion or differentiation of RBC progentors in new ways would have clear clinical utility.

摘要：调节红系祖细胞形成和分化为红细胞的途径对细胞的了解并不完全。我们发现，维生素D受体（Vdr）核激素转录因子基因在胎儿和成体阶段表达，但在胚胎发育阶段不表达，在成熟过程中下调。VDR被其配体维生素D3激活导致构象变化稳定蛋白质并诱导其移位到细胞核，在那里它招募共调节复合物。 VDR信号通路主要在骨中进行研究，但在骨中基本上未进行探索。红细胞生成：已发表的研究几乎全部在白血病细胞系（非正常原发性）中进行。细胞）。维生素D3激动剂骨化三醇激活Vdr信号增加了EryD集落的生长来自胎儿肝脏和成人骨髓，保持祖细胞潜能，并延迟红细胞成熟。的刺激红系祖细胞的生长导致成熟红细胞数量大幅增加细胞Linneg cKit+细胞的早期（CD 71 lo/neg）而非晚期（CD 71 hi）EryD祖细胞亚群是应答性的骨化三醇，独立于其钙离子效应。VDR的激活可以部分替代和与应激糖皮质激素地塞米松相比，单独的配体，表明在应激红细胞生成中的作用。我们的发现支持了这种可能性， Vdr中干扰DNA结合的红细胞特异性缺失导致发生网织红细胞增多症，更早，并且比对照动物对应激的反应更明显。Vdr表达的RNA抑制取消了骨化三醇对早期红系祖细胞生长的刺激。这些发现表明Vdr具有早期红系祖细胞的细胞内在功能。骨化三醇激活Vdr后，红系转录因子基因Gata 1、Fog 1和Klf 1。有趣的是，昼夜节律基因通过激活Vdr和糖皮质激素受体Gr以及时钟表达中的振荡而上调基因Per 1在红系祖细胞中被促进。生物钟基因Bmal 1是细胞增殖所必需的。对地塞米松的反应。因此，该提议的首要假设是Vdr和Gr 通过调节时钟基因表达部分调节红系祖细胞，功能协调发展的本申请将使用动物和细胞培养模型来探索生物钟的调制 Gr和Vdr在红系祖细胞中的基因表达及其功能关系激素受体TF。这些研究可能会导致识别新的分子靶点在红细胞可以利用这些祖细胞来开发贫血和其他红细胞疾病的新疗法。的能力以新的方式调节RBC祖细胞的离体扩增或分化将具有明确的临床用途。